http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107245074-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate | 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107245074-B |
titleOfInvention | Compound and preparation method thereof for treating cerebral infarction |
abstract | The present invention relates to a kind of for treating the compound of cerebral infarction, and the invention further relates to the preparation method of the compound and its purposes for the drug for being used to prepare treatment cerebral infarction.The compounds of this invention can substantially reduce the ligated rear thrombosis generated of rat vein, the brain infarction area of arteria cerebri media blocking rat can be obviously reduced, therefore, the compounds of this invention can antithrombotic, promote thrombolysis, can be used in the cerebral infarction such as prevention and treatment of cerebral thrombosis, cerebral embolism. |
priorityDate | 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.